CSPC Innovation Pharmaceutical Co., Ltd. (SHE: 300765)

CSPC Innovation Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	31,561	42,873	9,767	8,376	7,858	7,140
Market Cap Growth	134.83%	338.97%	16.61%	6.58%	10.06%	-
Enterprise Value	31,093	39,717	7,864	6,725	6,463	5,759
Last Close Price	22.60	30.26	7.20	6.92	6.46	5.85
PE Ratio	49.54	55.59	13.25	23.53	25.36	23.66
PS Ratio	14.60	17.14	3.72	4.53	5.96	5.68
PB Ratio	8.08	8.43	2.48	2.54	2.92	2.96
P/FCF Ratio	-50.46	51.56	18.54	86.64	33.97	34.12
P/OCF Ratio	-65.11	46.24	15.24	28.68	22.51	22.64
EV/Sales Ratio	14.60	15.88	2.99	3.64	4.91	4.58
EV/EBITDA Ratio	39.93	45.47	9.60	13.34	16.26	17.30
EV/EBIT Ratio	48.69	51.30	10.53	15.46	18.78	20.16
EV/FCF Ratio	-44.27	47.76	14.93	69.57	27.94	27.52
Debt / Equity Ratio	0.00	0.00	0.01	0.00	-	-
Debt / EBITDA Ratio	0.00	0.00	0.02	0.00	-	-
Debt / FCF Ratio	0.00	0.00	0.04	0.01	-	-
Asset Turnover	0.38	0.49	0.63	0.55	0.45	0.59
Inventory Turnover	4.61	5.93	5.97	5.59	4.97	4.84
Quick Ratio	2.33	7.77	5.00	5.31	7.54	4.46
Current Ratio	2.78	8.26	5.47	6.09	8.17	4.83
Return on Equity (ROE)	13.45%	16.73%	20.07%	13.12%	11.75%	16.02%
Return on Assets (ROA)	7.20%	9.47%	11.22%	8.12%	7.41%	8.42%
Return on Capital (ROIC)	8.31%	10.69%	12.86%	9.08%	8.43%	10.25%
Earnings Yield	2.02%	1.76%	7.44%	4.69%	3.82%	3.83%
FCF Yield	-2.23%	1.94%	5.39%	1.15%	2.94%	2.93%
Dividend Yield	1.17%	0.88%	0.96%	1.00%	0.55%	0.41%
Payout Ratio	59.60%	12.95%	11.30%	10.68%	9.34%	-
Buyback Yield / Dilution	4.73%	-3.82%	0.02%	-13.53%	-6.56%	-24.77%
Total Shareholder Return	5.90%	-2.94%	0.98%	-12.53%	-6.01%	-24.36%

Source: S&P Capital IQ. Standard template. Financial Sources.